Tru Independence LLC Edwards Lifesciences Corp Transaction History

Tru Independence LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$83.84 - $104.76 $473,276 - $591,370	-5,645 Closed	0 $0
Q1 2021 May 20, 2021	BUY	$78.68 - $90.67 $444,148 - $511,832	5,645 New	5,645 $472,000
Q3 2020 Nov 19, 2020	SELL	$67.19 - $87.44 $116,373 - $151,446	-1,732 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$57.54 - $76.95 $68,242 - $91,262	1,186 Added 217.22%	1,732 $120,000
Q4 2019 May 19, 2020	BUY	$71.7 - $82.09 $39,148 - $44,821	546 New	546 $103,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.